Protocol: Phytomedicine-AMARGOL®, Clinical Trial for Efficacy Proof on Therapeutics

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: Male

Summary

This is a Phase 3: Efficacy Study for AMARGOL® a phytomedicine used for asymptomatic digestive complaints.

• Phase: Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Laboratorio Saude Ltda.
• Collaborator: Phytopharm Consulting Brazil
• Treatments: Coal Tar

Criteria

Inclusion Criteria:

• 18-45 years old

• 65-85 Kg

• healthy volunteers

Exclusion Criteria:

• chronic dyspeptics illness chronic congestive cardiac problems

• pulmonary problems

• diabetes, thyroid problems

• pregnancy

• bowel syndrome

• hemorrhoids

• colitis

• allergies for any formula components.